CytomX Therapeutics, Inc. (CTMX)
2.91
-0.07
(-2.35%)
USD |
NASDAQ |
Jun 10, 16:00
2.895
-0.02
(-0.52%)
After-Hours: 20:00
CytomX Therapeutics Gross Profit Margin (Quarterly) : 97.55% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 97.55% |
| December 31, 2025 | 23.08% |
| September 30, 2025 | 97.75% |
| June 30, 2025 | 98.14% |
| March 31, 2025 | 99.24% |
| December 31, 2024 | 98.92% |
| September 30, 2024 | 98.72% |
| June 30, 2024 | 98.17% |
| March 31, 2024 | 98.87% |
| December 31, 2023 | 98.17% |
| September 30, 2023 | 94.60% |
| June 30, 2023 | 93.80% |
| March 31, 2023 | 93.63% |
| December 31, 2022 | 92.60% |
| September 30, 2022 | 86.68% |
| June 30, 2022 | 92.00% |
| March 31, 2022 | 84.20% |
| December 31, 2021 | 92.48% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 97.79% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 78.02% |
| Ocugen, Inc. | 61.51% |
| Catalyst Pharmaceuticals, Inc. | 83.82% |
| Rigel Pharmaceuticals, Inc. | 92.17% |
| iBio, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -44.05% |
| Return on Assets | -31.34% |
| Return on Invested Capital | -42.30% |
| Profit Margin (Quarterly) | -177.9% |
| Operating Margin (Quarterly) | -191.8% |
| Return on Net Operating Assets | -629.2% |